Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele C DeLuca

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
BMC Medical Genetics|July 9, 2008
Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosisSreeram V Ramagopalan, David A Dyment, Katie M Morrison, et al.
Annals of Clinical and Translational Neurology|September 15, 2017
Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?Francesco Grussu, Torben Schneider, Carmen Tur, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2013
Motor skill learning induces changes in white matter microstructure and myelinationCassandra Sampaio-Baptista, Alexandre A Khrapitchev, Sean Foxley, et al.
Brain Pathology (Zurich, Switzerland)|April 25, 2024
A role for vessel-associated extracellular matrix proteins in multiple sclerosis pathologyMarco Pisa, Joseph L Watson, Jonathan I Spencer, et al.
Plos Genetics|February 7, 2009
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin DSreeram V Ramagopalan, Narelle J Maugeri, Lahiru Handunnetthi, et al.
Glia|March 30, 2023
Microglia directly associate with pericytes in the central nervous systemGary P Morris, Catherine G Foster, Jo-Maree Courtney, et al.
Journal of Neurology|June 20, 2008
Analysis of 45 candidate genes for disease modifying activity in multiple sclerosisSreeram V Ramagopalan, Gabriele C Deluca, Katie M Morrison, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 9, 2020
Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosisRuth Geraldes, Maciej Juryńczyk, Giordani Dos Passos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2016
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody diseaseMaciej Juryńczyk, George Tackley, Yazhuo Kong, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 6, 2019
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosisShelly Coe, Jo Cossington, Johnny Collett, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
BMC Medical Genetics|July 9, 2008
Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosisSreeram V Ramagopalan, David A Dyment, Katie M Morrison, et al.
Annals of Clinical and Translational Neurology|September 15, 2017
Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?Francesco Grussu, Torben Schneider, Carmen Tur, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 17, 2013
Motor skill learning induces changes in white matter microstructure and myelinationCassandra Sampaio-Baptista, Alexandre A Khrapitchev, Sean Foxley, et al.
Brain Pathology (Zurich, Switzerland)|April 25, 2024
A role for vessel-associated extracellular matrix proteins in multiple sclerosis pathologyMarco Pisa, Joseph L Watson, Jonathan I Spencer, et al.
Plos Genetics|February 7, 2009
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin DSreeram V Ramagopalan, Narelle J Maugeri, Lahiru Handunnetthi, et al.
Glia|March 30, 2023
Microglia directly associate with pericytes in the central nervous systemGary P Morris, Catherine G Foster, Jo-Maree Courtney, et al.
Journal of Neurology|June 20, 2008
Analysis of 45 candidate genes for disease modifying activity in multiple sclerosisSreeram V Ramagopalan, Gabriele C Deluca, Katie M Morrison, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 9, 2020
Distinct influence of different vascular risk factors on white matter brain lesions in multiple sclerosisRuth Geraldes, Maciej Juryńczyk, Giordani Dos Passos, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2016
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody diseaseMaciej Juryńczyk, George Tackley, Yazhuo Kong, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 6, 2019
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosisShelly Coe, Jo Cossington, Johnny Collett, et al.
Pageof 9